Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 mRNA Translation Regulation
1.2.3 RNA Splicing Modification
1.2.4 Direct RNA Targeting
1.2.5 Indirect RNA Targeting - Epitranscriptomics
1.3 Market by Application
1.3.1 Global RNA-Targeted Small Molecules Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Phamacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA-Targeted Small Molecules Market Perspective (2018-2034)
2.2 RNA-Targeted Small Molecules Growth Trends by Region
2.2.1 Global RNA-Targeted Small Molecules Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 RNA-Targeted Small Molecules Historic Market Size by Region (2018-2023)
2.2.3 RNA-Targeted Small Molecules Forecasted Market Size by Region (2024-2034)
2.3 RNA-Targeted Small Molecules Market Dynamics
2.3.1 RNA-Targeted Small Molecules Industry Trends
2.3.2 RNA-Targeted Small Molecules Market Drivers
2.3.3 RNA-Targeted Small Molecules Market Challenges
2.3.4 RNA-Targeted Small Molecules Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA-Targeted Small Molecules Players by Revenue
3.1.1 Global Top RNA-Targeted Small Molecules Players by Revenue (2018-2023)
3.1.2 Global RNA-Targeted Small Molecules Revenue Market Share by Players (2018-2023)
3.2 Global RNA-Targeted Small Molecules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA-Targeted Small Molecules Revenue
3.4 Global RNA-Targeted Small Molecules Market Concentration Ratio
3.4.1 Global RNA-Targeted Small Molecules Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA-Targeted Small Molecules Revenue in 2024
3.5 RNA-Targeted Small Molecules Key Players Head office and Area Served
3.6 Key Players RNA-Targeted Small Molecules Product Solution and Service
3.7 Date of Enter into RNA-Targeted Small Molecules Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA-Targeted Small Molecules Breakdown Data by Type
4.1 Global RNA-Targeted Small Molecules Historic Market Size by Type (2018-2023)
4.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2024-2034)
5 RNA-Targeted Small Molecules Breakdown Data by Application
5.1 Global RNA-Targeted Small Molecules Historic Market Size by Application (2018-2023)
5.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America RNA-Targeted Small Molecules Market Size (2018-2034)
6.2 North America RNA-Targeted Small Molecules Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America RNA-Targeted Small Molecules Market Size by Country (2018-2023)
6.4 North America RNA-Targeted Small Molecules Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA-Targeted Small Molecules Market Size (2018-2034)
7.2 Europe RNA-Targeted Small Molecules Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe RNA-Targeted Small Molecules Market Size by Country (2018-2023)
7.4 Europe RNA-Targeted Small Molecules Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA-Targeted Small Molecules Market Size (2018-2034)
8.2 Asia-Pacific RNA-Targeted Small Molecules Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2018-2023)
8.4 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA-Targeted Small Molecules Market Size (2018-2034)
9.2 Latin America RNA-Targeted Small Molecules Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America RNA-Targeted Small Molecules Market Size by Country (2018-2023)
9.4 Latin America RNA-Targeted Small Molecules Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA-Targeted Small Molecules Market Size (2018-2034)
10.2 Middle East & Africa RNA-Targeted Small Molecules Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2018-2023)
10.4 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Accent Therapeutics
11.1.1 Accent Therapeutics Company Detail
11.1.2 Accent Therapeutics Business Overview
11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Introduction
11.1.4 Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.1.5 Accent Therapeutics Recent Development
11.2 Anima Biotech Inc.
11.2.1 Anima Biotech Inc. Company Detail
11.2.2 Anima Biotech Inc. Business Overview
11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Introduction
11.2.4 Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.2.5 Anima Biotech Inc. Recent Development
11.3 Arrakis Pharmaceuticals
11.3.1 Arrakis Pharmaceuticals Company Detail
11.3.2 Arrakis Pharmaceuticals Business Overview
11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Introduction
11.3.4 Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.3.5 Arrakis Pharmaceuticals Recent Development
11.4 Epics Therapeutics
11.4.1 Epics Therapeutics Company Detail
11.4.2 Epics Therapeutics Business Overview
11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Introduction
11.4.4 Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.4.5 Epics Therapeutics Recent Development
11.5 Expansion Therapeutics
11.5.1 Expansion Therapeutics Company Detail
11.5.2 Expansion Therapeutics Business Overview
11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Introduction
11.5.4 Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.5.5 Expansion Therapeutics Recent Development
11.6 Gotham Therapeutics
11.6.1 Gotham Therapeutics Company Detail
11.6.2 Gotham Therapeutics Business Overview
11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Introduction
11.6.4 Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.6.5 Gotham Therapeutics Recent Development
11.7 H3 Biomedicine
11.7.1 H3 Biomedicine Company Detail
11.7.2 H3 Biomedicine Business Overview
11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Introduction
11.7.4 H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.7.5 H3 Biomedicine Recent Development
11.8 Ribometrix
11.8.1 Ribometrix Company Detail
11.8.2 Ribometrix Business Overview
11.8.3 Ribometrix RNA-Targeted Small Molecules Introduction
11.8.4 Ribometrix Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.8.5 Ribometrix Recent Development
11.9 Skyhawk Therapeutics
11.9.1 Skyhawk Therapeutics Company Detail
11.9.2 Skyhawk Therapeutics Business Overview
11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Introduction
11.9.4 Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.9.5 Skyhawk Therapeutics Recent Development
11.10 STORM Therapeutics
11.10.1 STORM Therapeutics Company Detail
11.10.2 STORM Therapeutics Business Overview
11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Introduction
11.10.4 STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.10.5 STORM Therapeutics Recent Development
11.11 Twentyeight-Seven Therapeutics
11.11.1 Twentyeight-Seven Therapeutics Company Detail
11.11.2 Twentyeight-Seven Therapeutics Business Overview
11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Introduction
11.11.4 Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023)
11.11.5 Twentyeight-Seven Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global RNA-Targeted Small Molecules Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of mRNA Translation Regulation
Table 3. Key Players of RNA Splicing Modification
Table 4. Key Players of Direct RNA Targeting
Table 5. Key Players of Indirect RNA Targeting - Epitranscriptomics
Table 6. Global RNA-Targeted Small Molecules Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global RNA-Targeted Small Molecules Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global RNA-Targeted Small Molecules Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global RNA-Targeted Small Molecules Market Share by Region (2018-2023)
Table 10. Global RNA-Targeted Small Molecules Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global RNA-Targeted Small Molecules Market Share by Region (2024-2034)
Table 12. RNA-Targeted Small Molecules Market Trends
Table 13. RNA-Targeted Small Molecules Market Drivers
Table 14. RNA-Targeted Small Molecules Market Challenges
Table 15. RNA-Targeted Small Molecules Market Restraints
Table 16. Global RNA-Targeted Small Molecules Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global RNA-Targeted Small Molecules Market Share by Players (2018-2023)
Table 18. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Targeted Small Molecules as of 2024)
Table 19. Ranking of Global Top RNA-Targeted Small Molecules Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by RNA-Targeted Small Molecules Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players RNA-Targeted Small Molecules Product Solution and Service
Table 23. Date of Enter into RNA-Targeted Small Molecules Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA-Targeted Small Molecules Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2018-2023)
Table 27. Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2024-2034)
Table 29. Global RNA-Targeted Small Molecules Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2018-2023)
Table 31. Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2024-2034)
Table 33. North America RNA-Targeted Small Molecules Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America RNA-Targeted Small Molecules Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America RNA-Targeted Small Molecules Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe RNA-Targeted Small Molecules Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe RNA-Targeted Small Molecules Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe RNA-Targeted Small Molecules Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific RNA-Targeted Small Molecules Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America RNA-Targeted Small Molecules Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America RNA-Targeted Small Molecules Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America RNA-Targeted Small Molecules Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa RNA-Targeted Small Molecules Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2024-2034) & (US$ Million)
Table 48. Accent Therapeutics Company Detail
Table 49. Accent Therapeutics Business Overview
Table 50. Accent Therapeutics RNA-Targeted Small Molecules Product
Table 51. Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 52. Accent Therapeutics Recent Development
Table 53. Anima Biotech Inc. Company Detail
Table 54. Anima Biotech Inc. Business Overview
Table 55. Anima Biotech Inc. RNA-Targeted Small Molecules Product
Table 56. Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 57. Anima Biotech Inc. Recent Development
Table 58. Arrakis Pharmaceuticals Company Detail
Table 59. Arrakis Pharmaceuticals Business Overview
Table 60. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product
Table 61. Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 62. Arrakis Pharmaceuticals Recent Development
Table 63. Epics Therapeutics Company Detail
Table 64. Epics Therapeutics Business Overview
Table 65. Epics Therapeutics RNA-Targeted Small Molecules Product
Table 66. Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 67. Epics Therapeutics Recent Development
Table 68. Expansion Therapeutics Company Detail
Table 69. Expansion Therapeutics Business Overview
Table 70. Expansion Therapeutics RNA-Targeted Small Molecules Product
Table 71. Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 72. Expansion Therapeutics Recent Development
Table 73. Gotham Therapeutics Company Detail
Table 74. Gotham Therapeutics Business Overview
Table 75. Gotham Therapeutics RNA-Targeted Small Molecules Product
Table 76. Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 77. Gotham Therapeutics Recent Development
Table 78. H3 Biomedicine Company Detail
Table 79. H3 Biomedicine Business Overview
Table 80. H3 Biomedicine RNA-Targeted Small Molecules Product
Table 81. H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 82. H3 Biomedicine Recent Development
Table 83. Ribometrix Company Detail
Table 84. Ribometrix Business Overview
Table 85. Ribometrix RNA-Targeted Small Molecules Product
Table 86. Ribometrix Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 87. Ribometrix Recent Development
Table 88. Skyhawk Therapeutics Company Detail
Table 89. Skyhawk Therapeutics Business Overview
Table 90. Skyhawk Therapeutics RNA-Targeted Small Molecules Product
Table 91. Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 92. Skyhawk Therapeutics Recent Development
Table 93. STORM Therapeutics Company Detail
Table 94. STORM Therapeutics Business Overview
Table 95. STORM Therapeutics RNA-Targeted Small Molecules Product
Table 96. STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 97. STORM Therapeutics Recent Development
Table 98. Twentyeight-Seven Therapeutics Company Detail
Table 99. Twentyeight-Seven Therapeutics Business Overview
Table 100. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product
Table 101. Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2018-2023) & (US$ Million)
Table 102. Twentyeight-Seven Therapeutics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA-Targeted Small Molecules Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global RNA-Targeted Small Molecules Market Share by Type: 2024 VS 2034
Figure 3. mRNA Translation Regulation Features
Figure 4. RNA Splicing Modification Features
Figure 5. Direct RNA Targeting Features
Figure 6. Indirect RNA Targeting - Epitranscriptomics Features
Figure 7. Global RNA-Targeted Small Molecules Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global RNA-Targeted Small Molecules Market Share by Application: 2024 VS 2034
Figure 9. Hospitals Case Studies
Figure 10. Laboratories Case Studies
Figure 11. Phamacy Case Studies
Figure 12. RNA-Targeted Small Molecules Report Years Considered
Figure 13. Global RNA-Targeted Small Molecules Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global RNA-Targeted Small Molecules Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global RNA-Targeted Small Molecules Market Share by Region: 2024 VS 2034
Figure 16. Global RNA-Targeted Small Molecules Market Share by Players in 2024
Figure 17. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Targeted Small Molecules as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by RNA-Targeted Small Molecules Revenue in 2024
Figure 19. North America RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America RNA-Targeted Small Molecules Market Share by Country (2018-2034)
Figure 21. United States RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe RNA-Targeted Small Molecules Market Share by Country (2018-2034)
Figure 25. Germany RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific RNA-Targeted Small Molecules Market Share by Region (2018-2034)
Figure 33. China RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America RNA-Targeted Small Molecules Market Share by Country (2018-2034)
Figure 41. Mexico RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa RNA-Targeted Small Molecules Market Share by Country (2018-2034)
Figure 45. Turkey RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia RNA-Targeted Small Molecules Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Accent Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 48. Anima Biotech Inc. Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 49. Arrakis Pharmaceuticals Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 50. Epics Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 51. Expansion Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 52. Gotham Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 53. H3 Biomedicine Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 54. Ribometrix Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 55. Skyhawk Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 56. STORM Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 57. Twentyeight-Seven Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed